CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New strategy aims to shield patients from dangerous treatment side effect
Disease control OngoingThis early-stage study is testing a new order for giving approved drugs to patients whose chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) has returned or stopped responding to treatment. The goal is to see if giving two drugs (rituximab and methylprednisolo…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Race for a better, Time-Limited leukemia treatment
Disease control OngoingThis study is testing which of two drug combinations works better for people newly diagnosed with a type of slow-growing blood cancer (CLL/SLL). About 600 participants will receive either acalabrutinib with venetoclax or venetoclax with obinutuzumab. The goal is to see if a treat…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC